GSK plc (LON:GSK) Given Consensus Recommendation of “Hold” by Analysts

GSK plc (LON:GSK) has been assigned an average recommendation of “Hold” from the seven research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is GBX 1,630.63 ($20.64).

A number of equities research analysts have recently issued reports on GSK shares. Barclays reissued an “equal weight” rating and set a GBX 1,725 ($21.83) price objective on shares of GSK in a research report on Monday, April 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,950 ($24.68) target price on shares of GSK in a report on Tuesday, March 12th. Berenberg Bank upped their target price on shares of GSK from GBX 1,650 ($20.88) to GBX 1,820 ($23.04) and gave the stock a “buy” rating in a report on Wednesday, February 14th. Finally, Shore Capital reaffirmed a “buy” rating on shares of GSK in a report on Thursday, March 7th.

Insiders Place Their Bets

In other news, insider Emma Walmsley sold 139,792 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.98), for a total transaction of £2,317,751.36 ($2,933,491.15). In other news, insider Emma Walmsley sold 139,792 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.98), for a total transaction of £2,317,751.36 ($2,933,491.15). Also, insider Julie Brown bought 19,360 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were acquired at an average price of GBX 1,583 ($20.04) per share, for a total transaction of £306,468.80 ($387,886.09). Insiders have purchased a total of 19,802 shares of company stock worth $31,381,484 in the last 90 days. 1.71% of the stock is currently owned by corporate insiders.

GSK Trading Up 0.9 %

Shares of GSK stock opened at GBX 1,643.50 ($20.80) on Friday. GSK has a 1 year low of GBX 1,302.60 ($16.49) and a 1 year high of GBX 1,719.80 ($21.77). The firm has a fifty day moving average price of GBX 1,666.63 and a 200-day moving average price of GBX 1,542.69. The company has a debt-to-equity ratio of 140.82, a current ratio of 0.88 and a quick ratio of 0.73. The company has a market cap of £67.22 billion, a price-to-earnings ratio of 1,369.58, a PEG ratio of 1.09 and a beta of 0.27.

GSK Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, February 22nd were paid a GBX 16 ($0.20) dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a yield of 1.04%. This is a boost from GSK’s previous dividend of $14.00. GSK’s payout ratio is presently 5,333.33%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.